Other Species / Isoforms
  FGFR3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
N98
PQRLQVLNASHEDSG
0 1
FGFR3 (human) PQRLQVLNASHEDSG N98
FGFR3 iso2 (human) PQRLQVLNASHEDSG N98
FGFR3 iso3 (human) PQRLQVLNASHEDSG N98
FGFR3 (mouse) PQRLQVLnASHEDAG N96-ng
FGFR3 (rat) PQRLQVLNATHEDAG N96
N225
VVPSDRGNYTCVVEN
0 1
FGFR3 (human) VVPSDRGNYTCVVEN N225
FGFR3 iso2 (human) VVPSDRGNYTCVVEN N225
FGFR3 iso3 (human) VVPSDRGNYTCVVEN N225
FGFR3 (mouse) VVPSDRGnYTCVVEN N219-ng
FGFR3 (rat) VVPSDRGNYTCVVEN N219
N262
LQAGLPANQTAVLGS
0 1
FGFR3 (human) LQAGLPANQTAVLGS N262
FGFR3 iso2 (human) LQAGLPANQTAVLGS N262
FGFR3 iso3 (human) LQAGLPANQTAVLGS N262
FGFR3 (mouse) LQAGLPAnQTAILGS N256-ng
FGFR3 (rat) LQAGLPANQTAVLGS N256
N294
WLKHVEVNGSKVGPD
0 1
FGFR3 (human) WLKHVEVNGSKVGPD N294
FGFR3 iso2 (human) WLKHVEVNGSKVGPD N294
FGFR3 iso3 (human) WLKHVEVNGSKVGPD N294
FGFR3 (mouse) WLKHVEVnGSKVGPD N288-ng
FGFR3 (rat) WLKHVEVNGSKVGPD N288
N315
VLKTAGANTTDKELE
0 1
FGFR3 (human) VLKTAGANTTDKELE N315
FGFR3 iso2 (human) gap -
FGFR3 iso3 (human) gap -
FGFR3 (mouse) VLKTAGAnTTDKELE N309-ng
FGFR3 (rat) VLKTAGANTTDRELE N309
S408-p
PPKKGLGsPtVHkIS
0 4
FGFR3 (human) PPKKGLGsPtVHkIS S408-p
FGFR3 iso2 (human) PPKKGLGSPTVHKIS S410
FGFR3 iso3 (human) gap -
FGFR3 (mouse) PPKKGLGsPTVHKVS S402-p
FGFR3 (rat) PPKKGLGSPTVHKVS S402
T410-p
KKGLGsPtVHkISRF
0 1
FGFR3 (human) KKGLGsPtVHkISRF T410-p
FGFR3 iso2 (human) KKGLGSPTVHKISRF T412
FGFR3 iso3 (human) gap -
FGFR3 (mouse) KKGLGsPTVHKVSRF T404
FGFR3 (rat) KKGLGSPTVHKVSRF T404
K413-ub
LGsPtVHkISRFPLK
0 1
FGFR3 (human) LGsPtVHkISRFPLK K413-ub
FGFR3 iso2 (human) LGSPTVHKISRFPLK K415
FGFR3 iso3 (human) gap -
FGFR3 (mouse) LGsPTVHKVSRFPLK K407
FGFR3 (rat) LGSPTVHKVSRFPLK K407
S424-p
FPLKRQVsLESNASM
0 3
FGFR3 (human) FPLKRQVsLESNASM S424-p
FGFR3 iso2 (human) FPLKRQVSLESNASM S426
FGFR3 iso3 (human) YVTVLKVSLESNAsM S312
FGFR3 (mouse) FPLKRQVsLESNSSM S418-p
FGFR3 (rat) FPLKRQVSLESNSSM S418
S430
VsLESNASMSSNTPL
0 1
FGFR3 (human) VsLESNASMSSNTPL S430
FGFR3 iso2 (human) VSLESNASMSSNTPL S432
FGFR3 iso3 (human) VSLESNAsMSSNtPL S318-p
FGFR3 (mouse) VsLESNSSMNSNTPL S424
FGFR3 (rat) VSLESNSSMNSNTPL S424
T435
NASMSSNTPLVRIAR
0 1
FGFR3 (human) NASMSSNTPLVRIAR T435
FGFR3 iso2 (human) NASMSSNTPLVRIAR T437
FGFR3 iso3 (human) NAsMSSNtPLVRIAR T323-p
FGFR3 (mouse) NSSMNSNTPLVRIAR T429
FGFR3 (rat) NSSMNSNTPLVRIAR T429
S444-p
LVRIARLssGEGPtL
0 10
FGFR3 (human) LVRIARLssGEGPtL S444-p
FGFR3 iso2 (human) LVRIARLSSGEGPTL S446
FGFR3 iso3 (human) LVRIARLSSGEGPTL S332
FGFR3 (mouse) LVRIARLssGEGPVL S438-p
FGFR3 (rat) LVRIARLssGEGPVL S438-p
S445-p
VRIARLssGEGPtLA
Upstream
0 11
Treatment
  • U0126
FGFR3 (human) VRIARLssGEGPtLA S445-p
FGFR3 iso2 (human) VRIARLSSGEGPTLA S447
FGFR3 iso3 (human) VRIARLSSGEGPTLA S333
FGFR3 (mouse) VRIARLssGEGPVLA S439-p
FGFR3 (rat) VRIARLssGEGPVLA S439-p
T450-p
LssGEGPtLANVSEL
0 1
FGFR3 (human) LssGEGPtLANVSEL T450-p
FGFR3 iso2 (human) LSSGEGPTLANVSEL T452
FGFR3 iso3 (human) LSSGEGPTLANVSEL T338
FGFR3 (mouse) LssGEGPVLANVSEL V444
FGFR3 (rat) LssGEGPVLANVSEL V444
K530-ac
VSEMEMMkMIGKHKN
0 1
FGFR3 (human) VSEMEMMkMIGKHKN K530-ac
FGFR3 iso2 (human) VSEMEMMKMIGKHKN K532
FGFR3 iso3 (human) VSEMEMMKMIGKHKN K418
FGFR3 (mouse) VSEMEMMKMIGKHKN K524
FGFR3 (rat) VSEMEMMKMIGKHKN K524
Y552
CTQGGPLYVLVEYAA
0 2
FGFR3 (human) CTQGGPLYVLVEYAA Y552
FGFR3 iso2 (human) CTQGGPLYVLVEYAA Y554
FGFR3 iso3 (human) CTQGGPLYVLVEYAA Y440
FGFR3 (mouse) CTQGGPLyVLVEYAA Y546-p
FGFR3 (rat) CTQGGPLYVLVEYAA Y546
Y577-p
RRPPGLDysFDTCKP
Upstream
Downstream
1 9
Effects on Biological Processes:
  • cell growth, altered
Treatment
  • FGF1
  • PD173074
FGFR3 (human) RRPPGLDysFDTCKP Y577-p
FGFR3 iso2 (human) RRPPGLDYSFDTCKP Y579
FGFR3 iso3 (human) RRPPGLDYSFDTCKP Y465
FGFR3 (mouse) RRPPGMDYSFDACRL Y571
FGFR3 (rat) RRPPGMDYSFDACRL Y571
S578-p
RPPGLDysFDTCKPP
0 2
FGFR3 (human) RPPGLDysFDTCKPP S578-p
FGFR3 iso2 (human) RPPGLDYSFDTCKPP S580
FGFR3 iso3 (human) RPPGLDYSFDTCKPP S466
FGFR3 (mouse) RPPGMDYSFDACRLP S572
FGFR3 (rat) RPPGMDYSFDACRLP S572
Y599-p
KDLVSCAyQVARGME
Upstream
0 12
Putative in vivo kinases:
  • FGFR1 (mouse)
FGFR3 (human) KDLVSCAyQVARGME Y599-p
FGFR3 iso2 (human) KDLVSCAYQVARGME Y601
FGFR3 iso3 (human) KDLVSCAYQVARGME Y487
FGFR3 (mouse) KDLVSCAyQVARGME Y593-p
FGFR3 (rat) KDLVSCAYQVARGME Y593
Y607-p
QVARGMEyLASQKCI
0 2
FGFR3 (human) QVARGMEyLASQKCI Y607-p
FGFR3 iso2 (human) QVARGMEYLASQKCI Y609
FGFR3 iso3 (human) QVARGMEYLASQKCI Y495
FGFR3 (mouse) QVARGMEYLASQKCI Y601
FGFR3 (rat) QVARGMEYLASQKCI Y601
K632-ub
VTEDNVMkIADFGLA
0 2
FGFR3 (human) VTEDNVMkIADFGLA K632-ub
FGFR3 iso2 (human) VTEDNVMKIADFGLA K634
FGFR3 iso3 (human) VTEDNVMKIADFGLA K520
FGFR3 (mouse) VTEDNVMKIADFGLA K626
FGFR3 (rat) VTEDNVMKIADFGLA K626
Y647-p
RDVHNLDyyKKTTNG
Upstream
2 48
Kinase, in vitro:
  • FGFR3 (human)
Regulatory protein:
  • FGFR3 (human)
  • TACC3 (human)
Treatment
  • FGF1
  • FGF2
  • PD173074
FGFR3 (human) RDVHNLDyyKKTTNG Y647-p
FGFR3 iso2 (human) RDVHNLDYYKKTTNG Y649
FGFR3 iso3 (human) RDVHNLDYYKKTTNG Y535
FGFR3 (mouse) RDVHNLDyyKKTTNG Y641-p
FGFR3 (rat) RDVHNLDyyKKTTNG Y641-p
Y648-p
DVHNLDyyKKTTNGR
Upstream
1 18
Kinase, in vitro:
  • FGFR3 (human)
Treatment
  • FGF1
  • PD173074
FGFR3 (human) DVHNLDyyKKTTNGR Y648-p
FGFR3 iso2 (human) DVHNLDYYKKTTNGR Y650
FGFR3 iso3 (human) DVHNLDYYKKTTNGR Y536
FGFR3 (mouse) DVHNLDyyKKTTNGR Y642-p
FGFR3 (rat) DVHNLDyyKKTTNGR Y642-p
Y724-p
ANCTHDLyMIMRECW
Upstream
Downstream
2 3
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell growth, altered
  • transcription, altered
Putative in vivo kinases:
  • FGFR3 (human)
Treatment
  • FGF1
  • heparin sodium
FGFR3 (human) ANCTHDLyMIMRECW Y724-p
FGFR3 iso2 (human) ANCTHDLYMIMRECW Y726
FGFR3 iso3 (human) ANCTHDLYMIMRECW Y612
FGFR3 (mouse) ASCTHDLYMIMRECW Y719
FGFR3 (rat) ANCTHDLYMIMRECW Y718
Y760-p
TVTSTDEyLDLSAPF
Downstream
2 0
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, altered
FGFR3 (human) TVTSTDEyLDLSAPF Y760-p
FGFR3 iso2 (human) TVTSTDEYLDLSAPF Y762
FGFR3 iso3 (human) TVTSTDEYLDLSAPF Y648
FGFR3 (mouse) TVTSTDEYLDLSVPF Y755
FGFR3 (rat) TVTSTDEYLDLSVPF Y754
Y770-p
LSAPFEQysPGGQDt
Downstream
1 0
Effects on Biological Processes:
  • cell growth, altered
FGFR3 (human) LSAPFEQysPGGQDt Y770-p
FGFR3 iso2 (human) LSAPFEQYSPGGQDT Y772
FGFR3 iso3 (human) LSAPFEQYSPGGQDT Y658
FGFR3 (mouse) LSVPFEQYSPGGQDT Y765
FGFR3 (rat) LSVPFEQYSPGGQDT Y764
S771-p
SAPFEQysPGGQDtP
1 0
FGFR3 (human) SAPFEQysPGGQDtP S771-p
FGFR3 iso2 (human) SAPFEQYSPGGQDTP S773
FGFR3 iso3 (human) SAPFEQYSPGGQDTP S659
FGFR3 (mouse) SVPFEQYSPGGQDTP S766
FGFR3 (rat) SVPFEQYSPGGQDTP S765
T777-p
ysPGGQDtPSSSSSG
0 2
FGFR3 (human) ysPGGQDtPSSSSSG T777-p
FGFR3 iso2 (human) YSPGGQDTPSSSSSG T779
FGFR3 iso3 (human) YSPGGQDTPSSSSSG T665
FGFR3 (mouse) YSPGGQDTPSSSSSG T772
FGFR3 (rat) YSPGGQDTPSSSSSG T771
S787-p
SSSSGDDsVFAHDLL
0 2
FGFR3 (human) SSSSGDDsVFAHDLL S787-p
FGFR3 iso2 (human) SSSSGDDSVFAHDLL S789
FGFR3 iso3 (human) SSSSGDDSVFAHDLL S675
FGFR3 (mouse) SSSSGDDSVFTHDLL S782
FGFR3 (rat) SSSSGDDSVFTHDLL S781